(Q34627922)

3 August 2017

1 reference

title

Update information on human P450s (English)

1 reference

3 August 2017

F Peter Guengerich

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

3 August 2017

published in

Drug Metabolism Reviews

1 reference

3 August 2017

volume

34

1 reference

3 August 2017

issue

1-2

1 reference

3 August 2017

page(s)

7-15

1 reference

Drug and fatty acid hydroxylation by solubilized human liver microsomal cytochrome P-450—Phospholipid requirement

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Multiple forms of cytochrome P-450: Resolution and purification of rabbit liver aryl hydrocarbon hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

A new method for sequencing DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Baculovirus expression of bovine cytochrome P450c17 in Sf9 cells and comparison with expression in yeast, mammalian cells, and E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

New applications of bacterial systems to problems in toxicology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Purification of functional recombinant P450s from bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Drug metabolism by Escherichia coli expressing human cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Hybrid cytochromes P-450 identify a substrate binding domain in P-450IIC5 and P-450IIC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Genetic metabolic polymorphisms and the risk of cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Aryl hydrocarbon hydroxylase is inhibited by antibody to rat liver cytochrome P-450

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-120001386

21 January 2018

Identifiers

DOI

10.1081/DMR-120001386

1 reference

3 August 2017

1 reference